Perigon Wealth Management, LLC Dexcom Inc Transaction History

Perigon Wealth Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 29, 2024	BUY	$114.22 - $140.1 $6,167 - $7,565	54 Added 2.62%	2,114 $293,000
Q4 2023 Jan 29, 2024	BUY	$75.49 - $124.16 $155,509 - $255,769	2,060 New	2,060 $255,000
Q2 2023 Aug 02, 2023	BUY	$112.47 - $130.98 $208,406 - $242,705	1,853 New	1,853 $238,000
Q4 2022 Feb 14, 2023	BUY	$84.98 - $122.67 $271,256 - $391,562	3,192 New	3,192 $361,000
Q1 2021 May 17, 2021	SELL	$84.79 - $104.74 $4,917 - $6,074	-58 Closed	0 $0
Q4 2020 Jan 28, 2021	BUY	$78.0 - $104.5 $4,524 - $6,061	58 New	58 $21,000

1,113

365M

4.1M

3.65M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $25.5B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Perigon Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Perigon Wealth Management, LLC with notifications on news.